Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vita Life Sciences's Enterprise Value is A$95.67 Mil.
Vita Life Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$12.85 Mil. Therefore, Vita Life Sciences's EV-to-EBIT ratio for today is 7.45.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vita Life Sciences's Enterprise Value is A$95.67 Mil.
Vita Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was A$13.46 Mil. Therefore, Vita Life Sciences's EV-to-EBITDA ratio for today is 7.11.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vita Life Sciences's Enterprise Value is A$95.67 Mil.
Vita Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$79.51 Mil. Therefore, Vita Life Sciences's EV-to-Revenue ratio for today is 1.20.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Vita Life Sciences Enterprise Value Historical Data
The historical data trend for Vita Life Sciences's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vita Life Sciences's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vita Life Sciences's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vita Life Sciences's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Vita Life Sciences's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vita Life Sciences (ASX:VLS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vita Life Sciences's current Enterprise Value is A$95.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vita Life Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$12.85 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vita Life Sciences's current Enterprise Value is A$95.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vita Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was A$13.46 Mil.
Vita Life Sciences's current Enterprise Value is A$95.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vita Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$79.51 Mil.
Vita Life Sciences's current Enterprise Value is A$95.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vita Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$5.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vita Life Sciences Enterprise Value Related Terms
Thank you for viewing the detailed overview of Vita Life Sciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:VLS has been successfully added to your 